Glycopyrronium Bromide and Neostigmine Metilsulfate 0.5mg/2.5mg per ml Solution for Injection

• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor, pharmacist or nurse.
• If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

1. What Glycopyrronium and Neostigmine Injection is and what it is used for
2. What you need to know before you are given Glycopyrronium and Neostigmine Injection.
3. How Glycopyrronium and Neostigmine Injection is given.
4. Possible side effects.
5. How to store Glycopyrronium and Neostigmine Injection.
6. Contents of the pack and other information

• you are allergic to Glycopyrronium Bromide or Neostigmine Metilsulfate, or to any of the other ingredients in this medicine, (listed in section 6).
• you think you may have a blockage in your intestine or urinary passage.
• you have been given suxamethonium, a drug used to relax your muscles during surgery.

Take special care with Glycopyrronium and Neostigmine Injection. Tell your doctor if:

• you are pregnant or breast feeding;
• you suffer from glaucoma (increased pressure in the eye);
• you have had a recent operation on your intestines;
• you suffer from stomach ulcers;
• you suffer from asthma attacks, wheezing or difficulty breathing;
• you have a very slow heart beat (less than 60 beats per minute) or you are suffering from coronary artery disease; heart failure, irregular heartbeats or high or low blood pressure;
• you have recently suffered a heart attack;
• you have an overactive thyroid gland;
• you suffer from kidney problems;
• you suffer from myasthenia gravis (a disease resulting in severe muscle weakness and fatigue);
• you are suffering from epilepsy or Parkinson’s;
• you have a fever;
• you suffer from enlarged prostate gland;
• you suffer from obstruction of the stomach (pyloric stenosis) or bowel causing vomiting, abdominal pain and swelling (paralytic ileus);
• you are under the influence of anaesthetics like Cyclopropane or Halothane.

Tell your doctor or nurse if you are taking, have recently taken or might take any other medicines.

Medicines which may interact with Glycopyrronium and Neostigmine Injection include:

• suxamethonium, a drug used to relax your muscles during surgery;
• medicines used to treat bacterial infections known as aminoglycoside antibiotics, such as gentamicin and streptomycin;
• medicines used to treat bacterial infections known as polymyxins, such as colistimethate sodium;
• clindamycin, a medicine used to treat bacterial infections;
• medicines used to treat an irregular heartbeat, such as procainamide, propafenone and quinidine;
• chloroquine, a medicine used to treat and prevent malaria;
• lithium, a medicine used to treat bipolar disorder;
• medicines used to relax your muscles during surgery known as non-depolarising muscle relaxants
• propranolol, a medicine used to treat a number of conditions including migraines, heart problems and anxiety
• a type of medicine used to dry body secretions during surgery, known as antimuscarinics
• medicines to treat depressions (e.g. Tricyclic Antidepressant, MAOIs)
• Amantadine which is used to treat Parkinson’s disease or viral infections
• medicines used to treat mental illness (e.g. Nefopam)

This injection contains less than 1mmol (23mg) of sodium per 1ml (essentially ‘sodium-free’).

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before being given this medicine.

After having Glycopyrronium and Neostigmine Injection you should not drive or operate machinery until you have been advised that it is safe to do so because it can cause blurred vision and other effects that may affect your ability to do so. Do not drive or use machinery until these effects have gone

Adults and elderly patients:

Your doctor will inject 1-2ml into a vein over a period of 10 to 30 seconds. Alternatively, your doctor may inject a dose of 0.02ml per kg body weight into a vein over a period of 10 to 30 seconds, up to a maximum of 2ml.

Paediatric patients:

Your doctor will inject 0.02ml per kg body weight into a vein over a period of 10 to 30 seconds, up to a maximum of 2ml.

This medicine will be given to you in hospital so it is unlikely you will receive too much, however if you experience any of the following symptoms you should tell your doctor or nurse immediately:

• difficulty breathing
• you have too much saliva or increased sweating
• watering eyes or pinpoint pupils
• losing control of your bowels or bladder
• an unusually fast or slow or irregular heartbeat, or low blood pressure (you may feel faint)
• feeling agitated or an increase in the amount you dream
• weakness, muscle twitching or paralysis

If you have any further questions about this medicine, ask your doctor or nurse.

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below). By reporting side effects you can help provide more information on the safety of this medicine.

or search for MHRA Yellow Card in the Google Play or Apple App Store.

The active substances are Glycopyrronium Bromide and Neostigmine Metilsulfate. Each 1ml of Glycopyrronium and Neostigmine Injection contains 0.5mg of Glycopyrronium Bromide and 2.5mg of Neostigmine Metilsulfate.

The other ingredients are sodium phosphate, citric acid monohydrate, citric acid solution, sodium hydroxide and water for injections.

Glycopyrronium and Neostigmine Injection is a clear, colourless, sterile solution for injection.

Glycopyrronium and Neostigmine Injection is available in glass ampoules each containing 1ml of solution. Each carton supplied contains ten 1ml ampoules.

Marketing Authorisation Number: PL 00156/0116